Report: More Employers Are Looking To Deploy Value-Based Care
More than a third of employers are integrating accountable care into their health benefits, according to a new report from the Milken Institute. However, there are several barriers.
More than a third of employers are integrating accountable care into their health benefits, according to a new report from the Milken Institute. However, there are several barriers.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Under a new final rule, eligible DACA recipients will be able to enroll in a Qualified Health Plan through the ACA Marketplace or through a Basic Health Program.
Is a widened enforcement net squeezing physicians unfairly? That's the belief of one high-profile author and health policy expert.
As we enter the digital era of healthcare at scale, we must redefine how we care for people … and how we evaluate that care.
Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly and it’s now preparing for Phase 3 testing. But an oral obesity drug in Amgen’s pipeline will not advance beyond Phase 1.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Kaiser Permanente is deploying Innovaccer’s healthcare AI platform and population health management tools to support better value-based care — starting with its Washington market and potentially expanding to new markets in the future.
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big pharma M&A moves in the red-hot radiopharmaceuticals space.
Pepper Bio has licensed rights to lerociclib, a molecule that G1 Therapeutics designed to offer dosing and safety advantages over approved therapies in the same drug class. EQRx previously held rights to the drug, but returned them after the company was acquired last year.
The MedTech industry is poised for breakthroughs, owing to the rapid integration of digital ecosystems and technologies like AI and cloud.
A new eBook from HLTH and MedCity News captures how health insurers and their partners are using health tech to improve the patient experience, hea
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
In this month’s episode, Senior Reporter Katie Adams explored some executive hires and exits that recently occurred in the healthcare world, as well as layoffs affecting the industry. She also interviewed Adaeze Enekwechi, who became CEO of Cayaba Care this month.
Abbott earned FDA approval for its dissolving stent designed to unclog arteries below the knee. This marks the first time the FDA has approved a stent or drug-coated balloon to help arteries stay open below the knee.
The FDA approved X4 Pharmaceuticals drug Xolremdi for treating WHIM syndrome. The molecule, which addresses the underlying cause of this rare immunodeficiency, was licensed from Sanofi’s Genzyme subsidiary.